Verve Therapeutics
VERV
#7015
Rank
โ‚ฌ0.39 B
Marketcap
4,63ย โ‚ฌ
Share price
5.43%
Change (1 day)
-58.21%
Change (1 year)

Verve Therapeutics (VERV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.14 Billion

According to Verve Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.13 B15.86%
2022-12-31โ‚ฌ0.11 B405.93%
2021-12-31โ‚ฌ23.63 M-79.57%
2020-12-31โ‚ฌ0.11 B214.62%
2019-12-31โ‚ฌ36.77 M